Today during trading, shares of Knight Therapeutics Inc opened at $5.24 and closed at $5.34. Intraday prices ranged from a low of $5.24 to a high of $5.36.

The price advanced 1.52% from the previous day's close of $5.26.

Today across North America, the TSX Composite closed -0.50% at 22075.10, the S&P 500 closed -0.72% at 5205.81, the Dow Jones Industrial Average closed -1.00% at 39170.24 and the Nasdaq Composite closed -0.95% at 16240.45.

Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.

Trading volume was 56,867 on 214 total trades, with an average volume of 40,727 over the last 5 days.

Trading across the entire TSX saw 2,968 price advancers against 2,262 declines and 117 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $5.75 (January 22,2024) and low as $4.35 (October 23,2023). Moreover, the shares have advanced 20.81 percent in 52 weeks, while in 2024, they have advanced 2.89%.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $532.16 million on a float of 101,170 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Currently, Knight Therapeutics Inc's consensus rating is "Moderate Buy" based on 4 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..